Charleston, SC -- (SBWIRE) -- 11/01/2013 -- otcstockcenter.com, provide information specifically for trades in the micro cap market. Micro caps are companies with a capitalization between $50 million and $300 million. We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. Lets have a look on Few Hot Stocks, Pan Global Corp(OTCMKTS:PGLO), 3D EYE SOLUTIONS, IN(OTCMKTS:TDEY), Affymax, Inc.(OTCMKTS:AFFY), TRIBUNE CO 13 WTS (TRBNW)
Pan Global Corp(OTCMKTS:PGLO) closed latest trading day at $0.573, up +14.60%, on volume of over 4.63 million shares. The stock went up 128.8% in the last 5 days. Its average trading volume is 675,434.00 shares. In the time frame of the last one month, the share-price has surged almost 4.18%. Its market capitalization was $260.80 million. Pan Global, Corp. operates as a renewable energy technology and sustainable infrastructure company in the United States.
What was the Moving Force behind PGLO On Bullish Run? Read This Research Report on PGLO
With the latest rise of +6.76%, 3D EYE SOLUTIONS, IN(OTCMKTS:TDEY)now has YTD performance 2533.33% which for the week is positive at 19.7%. The total number of shares traded on the latest trading day was about 40.11 million shares, and changed hands at price range of $0.01 to $0.02 apiece. The company ended previous trading at $0.01. 3D Eye Solutions, Inc. engages in developing, providing, and integrating content conversion service for the 3D stereo and auto-stereo media industry in the United States.
For How Long TDEY will Fight for Profitability? Read This Trend Analysis report
Affymax, Inc.(OTCMKTS:AFFY) traded with -4.24% lost momentum to $1.13 in the latest trading session It captured $42.36 million in market value. The total number of shares traded on the latest trading day was about 333,432.00 shares. The day started out with an opening price of $1.15 and changed hands at price range of $1.11 to $1.20 apiece. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses.
Why Should Investors Buy AFFY After the Recent Fall? Just Go Here and Find Out
TRIBUNE CO 13 WTS (TRBNW) ended previous trading at $65.50, gaining +2.14%. The total number of shares traded on the latest trading day was about 192,040.00 shares. The stock has a 52-week high price of $68.30 and its 52-week low was recorded at $48.95.
Will TRBNW Continue To Move Higher? Find Out Here
About OTC Stock Center
We provide the information active traders need, when they need it. By combining our research capabilities with our instant alerts, subscribers are able to better determine trading strategies and execute those strategies faster. More trades can mean more profits to those who can take advantage of the picks included with our service. We provide high quality picks in a timely fashion so that you are free to do what you do best, which is trade for profit. Alertness.
Markets move on information. Our subscribers get our picks fast and first by signing up for our email and text alerts. This information is exclusively for our readers, but once it’s out, the markets move and move fast. Getting the right information is always important, getting it first and in time to be able to build your trades is even more important. Don’t miss out on the chance to take your trading to the next level.
OTC Stock Center’s sponsored advertisements do not purport to provide an analysis of any company’s financial position, operations or prospects and this is not to be construed as a recommendation by OTC Stock Center or an offer or solicitation to buy or sell any security. Neither the owner of OTC Stock Center nor any of its members, officers, directors, contractors or employees is licensed broker-dealers, account representatives, market makers, investment bankers, investment advisors, analyst or underwriters. Investing in securities, including the securities of those companies profiled or discussed on this website is for individuals tolerant of high risks. Viewers should always consult with a licensed securities professional before purchasing or selling any securities of companies profiled or discussed in our releases.
Please read Our Full Disclaimer at: http://otcstockcenter.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)